Orexo commences patent infringement litigation against Actavis for their generic versions of Suboxone® and Subutex® tablets in the US

Orexo commences patent infringement litigation against Actavis for their generic versions of Suboxone® and Subutex® tablets in the US

Date
March 1, 2017